This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-Researchers and Healthcare Providers
 Research Grants Program
-Medical and Scientific Advisory Council
 Recent Recommendations
 What is MASAC?
 All MASAC Recommendations
 MASAC Members
 Nursing Working Group
 Social Work Working Group
 Physical Therapy Working Group
 Comprehensive Medical Care - Hemophilia Treatment Centers
 Cell Based Coagulation Animation
 Rare Bleeding and Clotting Disorders Resource Room
 The Partners in Bleeding Disorders Education Program
 NHF/Novo Nordisk HANDI Library



MASAC Recommendation #94 - MASAC Resolution Regarding Consumer Participation in

MASAC Recommendation #94

MASAC Resolution Regarding Consumer Participation in the National Notification System

The following resolution was approved by the Medical and Scientific Advisory Council (MASAC) on November 6, 1999, and adopted by the NHF Board of Directors on December 21, 1999.

MASAC is concerned that the voluntary notification system for reporting problems with plasma-derived and recombinant clotting factor products has not been effectively promoted to consumers. Since effectiveness of the voluntary warning system is directly related to enrollment, we strongly encourage the IPPIA and National Notification System to develop more effective outreach strategies. We also strongly encourage distributors, home care companies, hemophilia treatment centers, and local chapters to actively inform consumers about the notification system. Privacy and confidentiality need to remain of paramount importance. We also urge consumers to enroll in this direct notification system as the quickest and most direct way of being notified of any recalls involving product that they might have in their possession but have not yet used.